These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21163133)

  • 1. Treatment of retinal vein occlusion in rabbits with traditional Chinese medicine Fufang XueShuan Tong.
    Zhou D; Wei WB; Yang CX; Ding N; Liu Y; He ML; Hou ZJ; Zhou JQ
    Chin Med J (Engl); 2010 Nov; 123(22):3293-8. PubMed ID: 21163133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular oedema and central retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Harino S; Sone T; Hori S
    Acta Ophthalmol; 2010 Sep; 88(6):646-51. PubMed ID: 19563372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Network pharmacology study of mechanism on xuesaitong injection against retinal vein occlusion].
    Wang LL; Zhao XP; Zhao ZY; Fan XH; Li Z
    Zhongguo Zhong Yao Za Zhi; 2014 Jun; 39(12):2322-5. PubMed ID: 25244768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
    Zhang H; Xia Y
    Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring ocular drug therapy by analysis of aqueous samples.
    Campochiaro PA; Choy DF; Do DV; Hafiz G; Shah SM; Nguyen QD; Rubio R; Arron JR
    Ophthalmology; 2009 Nov; 116(11):2158-64. PubMed ID: 19700195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branch retinal vein occlusion.
    Hamid S; Mirza SA; Shokh I
    J Ayub Med Coll Abbottabad; 2008; 20(2):128-32. PubMed ID: 19385476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion.
    Park SP; Ahn JK; Mun GH
    Retina; 2010 Feb; 30(2):281-6. PubMed ID: 19881397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Harino S; Hori S
    Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.
    Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Jian K; Sakamoto I; Nakano K; Yamashita H; Minamoto A; Mishima HK
    Am J Ophthalmol; 2005 Aug; 140(2):256-61. PubMed ID: 16086947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of Huoxue Tongmai Lishui method on fundus fluorescein angiography of non-ischemic retinal vein occlusion: a randomized controlled trial].
    Peng QH; Yao XL; Zeng ZC; Su RB; Wei YP
    Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1035-41. PubMed ID: 19912734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.
    McAllister IL; Vijayasekaran S; Chen SD; Yu DY
    Am J Ophthalmol; 2009 May; 147(5):838-46, 846.e1-2. PubMed ID: 19211093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history and histology in a rat model of laser-induced photothrombotic retinal vein occlusion.
    Zhang Y; Fortune B; Atchaneeyasakul LO; McFarland T; Mose K; Wallace P; Main J; Wilson D; Appukuttan B; Stout JT
    Curr Eye Res; 2008 Apr; 33(4):365-76. PubMed ID: 18398711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of anti-angiogenic drugs for central retinal vein occlusion].
    Waisbourd M; Loewenstein A
    Harefuah; 2010 Apr; 149(4):243-4, 261. PubMed ID: 20812499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resource use and costs of branch and central retinal vein occlusion in the elderly.
    Fekrat S; Shea AM; Hammill BG; Nguyen H; Kowalski JW; Schulman KA; Curtis LH
    Curr Med Res Opin; 2010 Jan; 26(1):223-30. PubMed ID: 19921963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic abnormalities associated with various types of retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Podhajsky P
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):180-96. PubMed ID: 11935275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
    Pinna A; Carru C; Solinas G; Zinellu A; Carta F
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2747-52. PubMed ID: 17525208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema.
    Shimura M; Nakazawa T; Yasuda K; Kunikata H; Shiono T; Nishida K
    Acta Ophthalmol; 2008 Jun; 86(4):377-84. PubMed ID: 18039346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.
    Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Hirayama T; Tamura H; Yamashita H; Minamoto A; Mishima HK
    Eye (Lond); 2008 Jan; 22(1):42-8. PubMed ID: 16826241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Fufang Xueshuantong Capsule on a rat model of retinal vein occlusion.
    Yuan YZ; Yuan F; Xu QY; Yu J; Li L; Zhang JL
    Chin J Integr Med; 2011 Apr; 17(4):296-301. PubMed ID: 21509674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
    Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
    Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.